Literature DB >> 28509265

Hepatitis C virus-related glomerulonephritis with acute kidney injury requiring hemodialysis that improved with virus removal and eradication using double-filtration plasmapheresis without interferon.

Akiko Morisue1, Kosuke Fukuoka2, Ruiko Goto1, Kosuke Ota1, Haruhiro Yamashita3, Yoko Shinno4, Ichiro Yamadori4.   

Abstract

A 66-year-old, hepatitis C virus (HCV)-positive woman was admitted to our hospital with oliguria, systemic edema, and rapid deterioration of renal function. Laboratory examination showed increased serum creatinine and decreased serum albumin levels, complement activity, and cryoglobulin positivity. The HCV RNA genotype was found to be 1b, and the viral load was high. Kidney biopsy examination showed type I membranoproliferative glomerulonephritis with capillary deposition of IgM and C3, indicating HCV-related glomerulonephritis. After hospitalization, hemodialysis was immediately required because of uremia and oliguria. Her renal function did not improve despite corticosteroid therapy. To treat the increasing HCV load, virus removal and eradication by double-filtration plasmapheresis therapy without interferon was performed, since the patient was allergic to interferon therapy. This treatment improved renal function and allowed the withdrawal from hemodialysis. This report presents a case of successful VRAD without interferon therapy in a patient with HCV-related glomerulonephritis and acute kidney injury that required hemodialysis.

Entities:  

Keywords:  HCV genotype 1b; Membranoproliferative glomerulonephritis; Virus removal and eradication by double-filtration plasmapheresis

Year:  2014        PMID: 28509265      PMCID: PMC5413711          DOI: 10.1007/s13730-014-0136-z

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  16 in total

1.  Virological effects and safety of combined double filtration plasmapheresis (DFPP) and interferon therapy in patients with chronic hepatitis C: A preliminary study.

Authors:  Tatsuya Yamashita; Kuniaki Arai; Akito Sakai; Eishiro Mizukoshi; Yoshio Sakai; Takashi Kagaya; Yasunari Nakamoto; Masao Honda; Takashi Wada; Hitoshi Yokoyama; Shuichi Kaneko
Journal:  Hepatol Res       Date:  2006-09-07       Impact factor: 4.288

Review 2.  Hepatitis C and renal disease: epidemiology, diagnosis, pathogenesis and therapy.

Authors:  Jose M Morales; N Kamar; L Rostaing
Journal:  Contrib Nephrol       Date:  2012-01-30       Impact factor: 1.580

Review 3.  Treatment of hepatitis C-mediated glomerular disease.

Authors:  Ana Maria Sandri; Usama Elewa; John J Poterucha; Fernando C Fervenza
Journal:  Nephron Clin Pract       Date:  2011-07-08

Review 4.  Hepatitis C treatment in patients with kidney disease.

Authors:  Fabrizio Fabrizi; Alessio Aghemo; Piergiorgio Messa
Journal:  Kidney Int       Date:  2013-07-03       Impact factor: 10.612

5.  Successful treatment of HCV-related cryoglobulinemic glomerulonephritis with double-filtration plasmapheresis and interferon combination therapy.

Authors:  Tomoko Namba; Rie Shiba; Takeshi Yamamoto; Yasuhiro Hirai; Takuma Moriwaki; Jun Matsuda; Hiroyuki Kadoya; Masanobu Takeji; Yukinori Yamada; Harumasa Yoshihara; Atsushi Yamauchi
Journal:  Clin Exp Nephrol       Date:  2010-05-14       Impact factor: 2.801

6.  Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load.

Authors:  Kenji Fujiwara; Shuichi Kaneko; Shinichi Kakumu; Michio Sata; Shuhei Hige; Eiichi Tomita; Satoshi Mochida
Journal:  Hepatol Res       Date:  2007-06-15       Impact factor: 4.288

7.  Clinicopathological analysis and therapy in hepatitis C virus-associated nephropathy.

Authors:  A Komatsuda; H Imai; H Wakui; K Hamai; H Ohtani; T Kodama; Y Oyama; A B Miura; Y Nakamoto
Journal:  Intern Med       Date:  1996-07       Impact factor: 1.271

Review 8.  Hepatitis C infection and chronic renal diseases.

Authors:  Norberto Perico; Dario Cattaneo; Boris Bikbov; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-07       Impact factor: 8.237

9.  Successful steroid treatment in a patient with membranoproliferative glomerulonephritis associated with hepatitis C virus.

Authors:  Toru Sanai; Izumi Watanabe; Tadashi Hirano; Masaru Nakayama; Hironori Sakai; Noriko Uesugi; Kohsuke Masutani; Ritsuko Katafuchi; Hideki Hirakata; Mitsuo Iida
Journal:  Int Urol Nephrol       Date:  2008-02-12       Impact factor: 2.370

10.  Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study.

Authors:  F Dammacco; D Sansonno; J H Han; V Shyamala; V Cornacchiulo; A R Iacobelli; G Lauletta; R Rizzi
Journal:  Blood       Date:  1994-11-15       Impact factor: 22.113

View more
  1 in total

Review 1.  Mechanistic Aspects and Therapeutic Potential of Quercetin against COVID-19-Associated Acute Kidney Injury.

Authors:  Lúcio Ricardo Leite Diniz; Marilia Trindade de Santana Souza; Allana Brunna Sucupira Duarte; Damião Pergentino de Sousa
Journal:  Molecules       Date:  2020-12-07       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.